CRYPTO:INJUSD

Injective Usd Stock News

etoro logo Buy INJUSD
*Your capital is at risk
$6.40
-0.110 (-1.69%)
At Close: Jun 03, 2026
Injective has just announced a new Revenue Fund aimed at boosting ecosystem growth just as the INJ token comes under pressure from a bearish chart pattern in the near term.
Injective (INJ) is leading the crypto market with a 26% recovery from the recent lows, suggesting a “strong” rally could be around the corner. Some analysts forecast further upside for the token i
This week, several crypto news stories are in the pipeline, with high potential to move the market. For some, however, the impact will be ecosystem-specific, with related tokens bound to exhibit volat
The altcoin market is strapping in for a rocky week ahead as major events are set to take place in the following days which would influence the rise and fall of prices in the market.
Injective (INJ), one of the prominent assets in the decentralized finance (DeFi) space, has taken a sharp hit, dropping by 12% within the last 24 hours. This sharp correction, one of the largest among
INJ long-term holders return, shaking up the market.
Injective Protocol is a cryptocurrency and blockchain project that aims to create a decentralized and fully interoperable ecosystem for decentralized finance (DeFi) and decentralized exchanges (DEXs).
The crypto market continued to trade in the red, registering a marginal decline over the past 24 hours as macroeconomic uncertainty and geopolitical tensions weighed on investor sentiment. The Federal
The crypto market continued trading in the green, registering a marginal increase as Bitcoin (BTC) and other cryptocurrencies registered marginal to notable increases after staying above key levels. B

Injective TVL Jumps 22% as INJ Price Holds Strong

11:04am, Thursday, 12'th Jun 2025
Rising TVL places Injective ahead of rivals as institutional interest and adoption gain pace
TL;DR Canary Capital sets up a Delaware trust for the “Staked INJ ETF,” marking the first step toward a potential ETF launch focused on Injective's native token. The proposed INJ ETF aims to offer
INJ token jumped over 5% to $13.60 following the creation of a Delaware trust by Canary Capital, hinting at early steps toward a potential staking-based ETF.
Canary Capital registered a Delaware Trust for an Injective (INJ) staking ETF, starting the first step of creating a new fund. Canary is yet to file with the SEC for the new ETF.
Canary Capital has registered a Delaware trust for a staked Injective ETF, marking an early step toward potentially launching a tradable INJ product in the U.S.
Fund manager Canary Capital has taken a typical first step for an ETF, creating a Delaware trust for a fund that would stake the Injective token.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE